Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors (MPNST).

Kolberg M, Bruun J, Murumägi A, Mpindi JP, Bergsland CH, Høland M, Eilertsen IA, Danielsen SA, Kallioniemi O, Lothe RA.

Mol Oncol. 2017 May 29. [Epub ahead of print]

PMID: 28556483

Published June 6, 2017 1:00 PM - Last modified June 6, 2017 1:00 PM